Global API Market 2019-2025

Global API Market Size, Share & Trends Analysis Report, by Type (Generic API and Branded API), by Type of Synthesis (Biotech API, Synthetic API, and Other API), by Therapeutics (CVD Drugs, Oncology Drugs, Neurology Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Others), and Forecast 2019-2025.

The global API market is estimated to witness a growth rate of around 6.5% over the period of 2019-2025. Growing prevalence of chronic and acute diseases, growing focus on precision medicine, and surging biopharmaceutical industries across the globe are driving the global API market. According to the WHO, around 17.9 million fatalities occurred globally due to cardiovascular diseases (CVDs) in 2016, representing around 31% of global fatalities. Amongst these fatalities, around 7.4 million were due to coronary heart diseases (CHD) and nearly 6.7 million were due to stroke. by 2030, it has been projected that CVDs would be responsible for nearly 23.6 million mortalities across the globe. These facts and figures reflect the demand for various pharmaceuticals drugs, which in turn, augments the demand for APIs.

The global API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. The growth of the branded segment is due to greater demand for patented drugs and their effectiveness as compared to generic drugs. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the global API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. NSAIDs therapeutics segment held the leading position in 2018.

Geographically, the market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America imports the majority of API from Asian and Sub-Saharan African countries and is estimated to dominate the global API market over the forecast period. Major factors backing the growth of the North American API market include the presence of major pharmaceutical firms such as Abbott Laboratories, AbbVie Inc., Dr. Reddy's Laboratories Ltd., and so on.

The global API market is fragmented in nature with the presence of various players operating in the market. Some of the prominent players that contribute significantly in the market include Teva Pharmaceutical Industries Ltd., Cipla Ltd., Almac Group, Sun Pharmaceutical Industries Ltd., and Thermo Fisher Scientific Inc. Teva Pharmaceutical Industries Ltd. is one of the major players in the global API market. The strong foothold of the company is attributed to its broad portfolio of more than 370 high-quality API products.

Research Methodology

The market study of the global API market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, pharmaceutical drug manufacturers, API manufacturers, raw material suppliers, distributors, traders, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global API Market Research and Analysis by Type
2. Global API Market Research and Analysis by Type of Synthesis
3. Global API Market Research and Analysis by Therapeutics

The Report covers:

• Comprehensive research methodology of global API market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting global API market.
• Insights about market determinants that are stimulating global API market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.